KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $54.3 million.

  • Medpace Holdings' Other Accumulated Expenses rose 4544.26% to $54.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.3 million, marking a year-over-year increase of 4544.26%. This contributed to the annual value of $53.6 million for FY2024, which is 3262.04% up from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Other Accumulated Expenses is $54.3 million, which was up 4544.26% from $44.9 million recorded in Q2 2025.
  • Medpace Holdings' Other Accumulated Expenses' 5-year high stood at $62.5 million during Q1 2023, with a 5-year trough of $21.2 million in Q2 2021.
  • Over the past 5 years, Medpace Holdings' median Other Accumulated Expenses value was $37.3 million (recorded in 2024), while the average stood at $39.2 million.
  • As far as peak fluctuations go, Medpace Holdings' Other Accumulated Expenses surged by 9693.91% in 2023, and later plummeted by 2865.14% in 2024.
  • Medpace Holdings' Other Accumulated Expenses (Quarter) stood at $27.6 million in 2021, then soared by 72.2% to $47.5 million in 2022, then fell by 14.95% to $40.4 million in 2023, then surged by 32.62% to $53.6 million in 2024, then increased by 1.28% to $54.3 million in 2025.
  • Its Other Accumulated Expenses stands at $54.3 million for Q3 2025, versus $44.9 million for Q2 2025 and $56.2 million for Q1 2025.